Catabolism of CoA

CoA undergoes dephosphorylation, catalyzed by lysosomal acid phosphatase, to dephospho-CoA, followed by pyrophosphatase action to release 4'-phosphopantetheine and 5 -AMP - the reverse of the final stages of CoA synthesis shown in Figure 12.2. CoA is also a substrate for direct pyrophosphatase action, at about 10% of the rate of action on dephospho-CoA. The pyrophosphatase seems to be a general nucleotide pyrophosphatase of plasma membrane rather than an enzyme specific for the degradation of CoA.

Phosphopantetheine, arising from either the catabolism of CoA or the inac-tivation of holo-acyl carrier protein (ACP), can be reutilized for CoA synthesis. Phosphopantetheine is a potent inhibitor of pantothenic acid kinase, the first step of de novo CoA synthesis.

Alternatively, phosphopantetheine is dephosphorylated, again by a relatively unspecific phosphatase. The resultant pantetheine is cleaved by pante-theinase, a specific amidase, to pantothenic acid and cysteamine. The resultant cysteamine may be an important precursor of taurine (Section 14.5.1). Pan-tetheinase is found in both the liver and kidneys. The kidney isoenzyme acts on both pantetheine and (at a lower rate) on phosphopantetheine, whereas the liver enzyme acts only on pantetheine (Dupreetal., 1973; Wittweretal., 1983).

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook


Post a comment